Influence of early ART on antibody detection in children
Polly Clayden, HIV i-Base Use of standard antibody tests in early treated children can lead to confusion according to data presented at the 6th International Workshop on HIV Paediatrics. There have...
View ArticleTime to first-line failure in the IeDEA cohort
Polly Clayden, HIV i-Base High rates of death, loss to follow up and first-line failure were observed in the IeDEA paediatric cohort, within five years of starting antiretroviral treatment (ART). Only...
View ArticleRationalising the paediatric antiretroviral formulary in Malawi
Polly Clayden, HIV i-Base Rationalising the national paediatric antiretroviral formulary Malawi significantly decreased the cost of paediatric HIV treatment and improved lead times for products,...
View Article3TC or FTC monotherapy suboptimal as a bridging strategy for adolescents
Polly Clayden, HIV i-Base Monotherapy with lamivudine or emtricitabine (3TC or FTC) is suboptimal as a bridging strategy for adolescents compared to failing antiretroviral treatment (ART) regimen...
View ArticleIs d4T a viable option for children in low-income countries?
Polly Clayden, HIV i-Base Two African studies presented at the 6th International Workshop on HIV Paediatrics looked at whether or not stavudine (d4T) is a viable option for children in low-income...
View ArticleUpdate on paediatric antiretrovirals
Polly Clayden, HIV i-Base Updates on the paediatric development of rilpivirine and the single tablet regimen of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate were shown at the 6th...
View Article6th International Workshop on HIV Paediatrics, 18-19 July 2014, Melbourne
The International Workshop on HIV Pediatrics is now up to number six – an annual fixture before the IAS conference – and goes from strength to strength. The meeting is an opportunity to show work on a...
View Article
